CLINICAL TRIALS PROFILE FOR DSUVIA
✉ Email this page to a colleague
All Clinical Trials for dsuvia
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04387136 ↗ | Intraoperative Sublingual Sufentanil for Acute Pain in the Ambulatory Surgery Center | Completed | University of Minnesota | Phase 4 | 2020-10-14 | The purpose of this study is to determine if a single dose of sublingual sufentanil given 15-30 minutes prior to wake up is efficacious at reducing recovery room time. |
| NCT04716413 ↗ | Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment | Recruiting | Montefiore Medical Center | Phase 4 | 2021-05-01 | In this case, series, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the PACU in ambulatory surgery patients taking Suboxone. |
| NCT05288348 ↗ | DSUVIA Early Evaluation of Pain Trial | Not yet recruiting | United States Department of Defense | Phase 3 | 2022-04-01 | Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain |
| NCT05288348 ↗ | DSUVIA Early Evaluation of Pain Trial | Not yet recruiting | Frank Guyette | Phase 3 | 2022-04-01 | Randomized, interventional trial of Emergency Department (ED) administration of DSUVIA (sufentanil) versus standard care pain management comparing pain treatment outcomes in injured patients with moderate to severe pain |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for dsuvia
Condition Name
Clinical Trial Locations for dsuvia
Trials by Country
Clinical Trial Progress for dsuvia
Clinical Trial Phase
Clinical Trial Sponsors for dsuvia
Sponsor Name
